tiprankstipranks
Advertisement
Advertisement
CytomX Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe FlyCytomX Therapeutics initiated with an Outperform at Wolfe Research
16d ago
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
Premium
Company Announcements
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
19d ago
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
Premium
The Fly
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
24d ago
CytomX Therapeutics Signals Progress in Varseta-M Trial
PremiumCompany AnnouncementsCytomX Therapeutics Signals Progress in Varseta-M Trial
2M ago
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
2M ago
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
Premium
The Fly
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
2M ago
CytomX Therapeutics 45.9M share Secondary priced at $5.30
PremiumThe FlyCytomX Therapeutics 45.9M share Secondary priced at $5.30
3M ago
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
Premium
The Fly
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
3M ago
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
Premium
The Fly
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100